Document is current
Any future updates will be listed below
-
Authors
Wyatt, Rebecca C.
Olek, Sven
De Franco, Elisa
Samans, Bjoern
Patel, Kashyap
Houghton, Jayne
Walter, Steffi
Schulze, Janika
Bacchetta, Rosa
Hattersley, Andrew T.
Flanagan, Sarah E.
Johnson, Matthew B. https://orcid.org/0000-0002-6519-6687
-
Funding
Funding for this research was provided by:
Research England
Wellcome Trust (219606/Z/19/Z, 105636/Z/14/Z)
Diabetes UK (19/005971)
- License Information
-
More Information
Article History
Received: 12 July 2022
Accepted: 21 December 2022
First Online: 5 January 2023
Declarations
:
: This study was approved by the Genetic Beta Cell Research Bank, Exeter, UK. Ethical approval was provided by the North Wales Research Ethics Committee, UK (IRAS project ID 231760).
: All study participants gave informed consent, or assent was obtained where children were too young, and parental consent was provided, in accordance with the declaration of Helsinki.
: Not applicable.
: Sven Olek has equity interest in Precision for Medicine, the owner of the epigenetic markers used in this study. No other authors have any competing interest.
